Dechra Announces FDA Approval of Zygolide® (pergolide tablets) for the Control of Clinical Signs Associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in Horses Zygolide® is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback